ANIK Anika Therapeutics Inc.
$21.35▲ +0.38%
Healthcare
Other
After hours
$21.35▲ +0.00%
Oct 27, 4:00 PM ET
Volume 82.9K
Avg Volume (10D) 105.4K
Key Metrics & Fundamentals
Market Cap
$285.73M
P/E Ratio
–
Div Yield
0.00%
52W Range
9.01 - 22.88
% vs 50 MA
3.34%
% vs 200 MA
34.31%
RSI-14
60.3
MACD Histogram
+0.1700
Beta (1Y vs SPY)
0.56
Free Cash Flow
-$2.13M
Gross Rev
$32.61M
Gross Profit
$21.24M
EBITDA
$4.46M
COGS
$11.37M
Operating Exp
$18.29M
Operating Income
$2.95M
EBIT
$2.95M
Pretax Income
$3.38M
Net Income
$3.31M
EPS (Diluted)
0.24
Price & Volume History
Loading chart…
Recent News
Anika to Issue Third Quarter 2026 Financial Results on Friday, November 6, 2026
GlobeNewswire · Oct 22, 2026 4:01 PM ET
Merck's Remigromig Meets Main Goal in Diabetic Macular Edema Study
Zacks · Sep 25, 2026 10:19 AM ET
Is Anika Therapeutics (ANIK) Outperforming Other Medical Stocks This Year?
Zacks · Sep 25, 2026 8:40 AM ET
AMGN's Dazodalibep Meets Goal in Systemic Sjogren's Disease Study
Zacks · Sep 23, 2026 10:38 AM ET
NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication
Zacks · Sep 21, 2026 11:57 AM ET
PBYI's Alisertib Combo Phase II Study in Small Cell Lung Cancer Begins
Zacks · Sep 18, 2026 10:48 AM ET
RCKT Aligns With FDA on Completing Phase II Study in Danon Disease
Zacks · Sep 16, 2026 10:56 AM ET
Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study
Zacks · Sep 15, 2026 11:22 AM ET
Roche Gets FDA Priority Tag for Enspryng in Rare Autoimmune Disorder
Zacks · Sep 10, 2026 11:42 AM ET
Novartis' Del-desiran Fails Late-Stage DM1 Study, Shares Fall
Zacks · Sep 9, 2026 2:47 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ANIK's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.